The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Nicole M. A. Blijlevens

Department of Hematology

University Medical Center St Radboud

PO Box 9101 6500 HB Nijmegen

Netherlands

[email]@*.umcn.nl

Name/email consistency: high

 
 
 
 
 
 
 

Affiliation

  • Department of Hematology, University Medical Center St Radboud, PO Box 9101 6500 HB Nijmegen, Netherlands. 2004 - 2009

References

  1. The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Mucositis: from febrile neutropenia to febrile mucositis. Blijlevens, N.M., Logan, R.M., Netea, M.G. J. Antimicrob. Chemother. (2009) [Pubmed]
  2. Neutropenic enterocolitis: challenges in diagnosis and treatment. Blijlevens, N.M. Clin. Adv. Hematol. Oncol (2009) [Pubmed]
  3. Prospective oral mucositis audit: oral mucositis in patients receiving high-dose melphalan or BEAM conditioning chemotherapy--European Blood and Marrow Transplantation Mucositis Advisory Group. Blijlevens, N., Schwenkglenks, M., Bacon, P., D'Addio, A., Einsele, H., Maertens, J., Niederwieser, D., Rabitsch, W., Roosaar, A., Ruutu, T., Schouten, H., Stone, R., Vokurka, S., Quinn, B., McCann, S. J. Clin. Oncol. (2008) [Pubmed]
  4. Cytotoxic treatment-induced gastrointestinal symptoms. Blijlevens, N.M. Curr. Opin. Support. Palliat. Care (2007) [Pubmed]
  5. Palifermin (recombinant keratinocyte growth factor-1): a pleiotropic growth factor with multiple biological activities in preventing chemotherapy- and radiotherapy-induced mucositis. Blijlevens, N., Sonis, S. Ann. Oncol. (2007) [Pubmed]
  6. Determining mucosal barrier injury to the oesophagus using CT scan. Blijlevens, N.M., Donnelly, J.P., Yakar, D., van Die, C.E., de Witte, T. Support. Care. Cancer (2007) [Pubmed]
  7. Prospective evaluation of gut mucosal barrier injury following various myeloablative regimens for haematopoietic stem cell transplant. Blijlevens, N.M., Donnelly, J.P., de Pauw, B.E. Bone Marrow Transplant. (2005) [Pubmed]
  8. Inflammatory response to mucosal barrier injury after myeloablative therapy in allogeneic stem cell transplant recipients. Blijlevens, N.M., Donnelly, J.P., DePauw, B.E. Bone Marrow Transplant. (2005) [Pubmed]
  9. A randomised, double-blinded, placebo-controlled, pilot study of parenteral glutamine for allogeneic stem cell transplant patients. Blijlevens, N.M., Donnelly, J.P., Naber, A.H., Schattenberg, A.V., DePauw, B.E. Support. Care. Cancer (2005) [Pubmed]
  10. Implications of treatment-induced mucosal barrier injury. Blijlevens, N.M. Curr. Opin. Oncol (2005) [Pubmed]
  11. Measuring mucosal damage induced by cytotoxic therapy. Blijlevens, N.M., van't Land, B., Donnelly, J.P., M'Rabet, L., de Pauw, B.E. Support. Care. Cancer (2004) [Pubmed]
  12. Citrulline: a potentially simple quantitative marker of intestinal epithelial damage following myeloablative therapy. Blijlevens, N.M., Lutgens, L.C., Schattenberg, A.V., Donnelly, J.P. Bone Marrow Transplant. (2004) [Pubmed]
 
WikiGenes - Universities